Skip to main content

Bristol Myers Squibb

Bristol Myers Squibb is a publicly listed biopharmaceutical company headquartered in the United States. It discovers, develops and markets innovative medicines for serious diseases in oncology, hematology, immunology, cardiovascular and neuroscience areas. Its major products include Opdivo, Eliquis and Revlimid, and its strategic growth was enhanced by the acquisition of Celgene. The company is included in the Forbes Global 2000, Fortune 500 and Fortune Global 500, and is among the largest global pharmaceutical firms.

North America
Pharmaceuticals & Biotechnology
Public
Not Engaged
Visit Website
ACT Core
C Inconsequential planning
Just Transition
0.0/100
Nature Benchmark
16.0/100
Social Benchmark
21.8/100
Gender Assessment
29.5/100
On this page

Subscribe to stay informed on our work

Keep up to date with all the latest from World Benchmarking Alliance

Join our newsletter